InvestorsHub Logo
Followers 4
Posts 1483
Boards Moderated 0
Alias Born 12/11/2013

Re: None

Wednesday, 03/07/2018 8:27:53 AM

Wednesday, March 07, 2018 8:27:53 AM

Post# of 38634
I consider unfair that

they never provided with a revenue split between focalin-seroquel

I consider redicoulous that

IF they did pay in advance for new oxy studies they didn't inform shareholders


I consider outrageous that

in one of his rare interviews Odidi talks about many other project his running but nobody knows about it


These are examples of how the Odidis doesn't give a s....t about shareholders, and if there is the option to sacrifice them he wouldn't be so difficult for him to issue new shares and disintegrate our investments (becoming himself a minority interest in the co...but I am not sure he understands the risk...and honestly he would deserve it)